1 completed, 1 terminated, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Immunocompromised: new trials by email Literature Review of Immunocompromised trials Research Report on Immunocompromised
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19 Nirmatrelvir, Ritonavir, Placebo for nirmatrelvir - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19) | Phase 2 | Withdrawn | Pfizer | 2022-12-13 | 2023-03-01 | |
| Seasonal Flu Vaccine in Adult Transplant Recipients Fluad 1x - Immunocompromised, Transplanted | Phase 2 | Completed | HepNet Study House, German Liverfoundation | 122 | 2010-11-01 | 2012-04-16 |
| H1N1sw Vaccine in Adult Transplant Recipients Focetria (2x H1N1 vaccine with MF59 adjuvants) - Immunocompromised | Phase 2 | Terminated | HepNet Study House, German Liverfoundation | 13 | 2010-02-01 | 2012-04-16 |
COVID-19 (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Ritonavir (1) · focetria (1) · nirmatrelvir (1) · nirmatrelvir and ritonavir drug combination (1)
HepNet Study House, German Liverfoundation (2) · Pfizer (1)
Germany (2) · Bulgaria (1) · United States (1)
2009 (1)